Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.20.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
12 Months Ended
Jan. 01, 2019
Sep. 10, 2018
Jan. 01, 2018
Apr. 06, 2017
Dec. 31, 2019
Dec. 31, 2018
Sep. 09, 2018
Dec. 30, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]                
Stockholders' Equity Note, Stock Split   1 share for every 2.5 shares of common stock            
Common Stock, Shares, Issued (in Shares)   16,133,544     23,323,087 16,868,783 40,333,758  
Cash, Uninsured Amount         $ 11,608,582 $ 4,200,160    
Inventory, Net         577,690 0    
Retainage Deposit         100,000      
Research and Development Expense         $ 9,738,819 $ 4,368,784    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)         3,980,804 3,135,828   3,404,131
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in Shares)         2,874,017 3,007,946    
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent     21.00%   21.00% 21.00%    
Registration Payment Arrangement, Accrual Carrying Value         $ 0 $ 0    
Operating Lease, Liability $ 422,215       723,419      
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability $ 419,000       $ 511,236 0    
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity     $ 3,044,162     $ 3,044,162    
Patents [Member]                
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]                
Finite-Lived Intangible Asset, Useful Life         20 years      
Minimum [Member]                
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]                
Property, Plant and Equipment, Useful Life         3 years      
Maximum [Member]                
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]                
Property, Plant and Equipment, Useful Life         5 years      
NeuroClear Technologies, Inc ("NeuroClear") [Member]                
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]                
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares)         896,690      
Subsidiary or Equity Method Investee, Cumulative Proceeds Received on All Transactions         $ 5,011,309      
Equity Method Investment, Ownership Percentage         87.80%      
Private Placement [Member]                
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]                
Units, Description       each unit consisting of one share of the Company’s common stock and a warrant to purchase one half of one share of common stock